1. Home
  2. SKYH vs CANF Comparison

SKYH vs CANF Comparison

Compare SKYH & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

N/A

Current Price

$10.10

Market Cap

418.4M

Sector

Industrials

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$2.36

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYH
CANF
Founded
2017
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.4M
6.7M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
SKYH
CANF
Price
$10.10
$2.36
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$13.13
$50.00
AVG Volume (30 Days)
127.8K
195.3K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
105.11
N/A
EPS
N/A
N/A
Revenue
$27,540,000.00
N/A
Revenue This Year
$78.89
$2,715,455.50
Revenue Next Year
$73.15
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
86.57
N/A
52 Week Low
$8.22
$0.17
52 Week High
$11.70
$10.40

Technical Indicators

Market Signals
Indicator
SKYH
CANF
Relative Strength Index (RSI) 42.16 33.18
Support Level $10.01 $0.17
Resistance Level $10.16 $3.59
Average True Range (ATR) 0.22 0.14
MACD -0.05 -0.09
Stochastic Oscillator 17.28 12.50

Price Performance

Historical Comparison
SKYH
CANF

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: